By Drug Target Review2024-05-31T12:00:23
Researchers have developed a new, compact EbCas12a variant that can be packaged into an all-in-one AAV system with its crRNA.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2023-03-20T13:41:33
Sponsored by Bio-Techne
2024-01-09T09:30:19
Sponsored by Sartorius
2023-07-04T10:05:58
Sponsored by Revvity
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud